Cite
HARVARD Citation
Yekedüz, E. et al. (2021). Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumors. International journal of cancer. 149 (7), pp. 1455-1462. [Online].